Back to Search
MICHELLE BOROWITZ, PHD
PHD
Clinical Psychologist
NPI: 1871177535Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
PY61075106(WA)
Research & Publications (20)
Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
PMID 18831072·Cytometry B Clin Cytom·2009
8-other
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
PMID 19129520·N Engl J Med·2009
8-other
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
PMID 19357394·Blood·2009
6-review
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning.
PMID 19167684·Biol Blood Marrow Transplant·2009
3-trial
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.
PMID 19176441·JAMA·2009
8-other
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
PMID 18711187·J Clin Oncol·2008
2-rct
Lymphadenopathy as the primary manifestation of malignant transformation in two patients with severe congenital neutropenia.
PMID 18213714·Pediatr Blood Cancer·2008
5-case
Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study.
PMID 18669463·J Clin Oncol·2008
3-trial
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.
PMID 18261793·Leuk Res·2008
8-other
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
PMID 18388178·Blood·2008
8-other
Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group.
PMID 18182569·Blood·2008
8-other
Epstein-Barr virus-associated central nervous system lymphoproliferative disease in a patient with acquired immunodeficiency syndrome responsive to highly active antiretroviral therapy.
PMID 18419459·Clin Infect Dis·2008
5-case
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
PMID 17003380·Blood·2007
4-observational
2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications.
PMID 17803188·Cytometry B Clin Cytom·2007
6-review
The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B-cell lymphomas.
PMID 16753591·Am J Clin Pathol·2006
8-other
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.
PMID 16822902·Blood·2006
8-other
Resolution of ambiguous low-level positive quantitative polymerase chain reaction results in TEL-AML1 positive ALL using a post-PCR fluorescent oligoligation method.
PMID 16984387·Br J Haematol·2006
8-other
Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma.
PMID 17169812·Leuk Lymphoma·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1660 S COLUMBIAN WAY, MAIL STOP: S-116-DDTP
SEATTLE, WA 98108 - Phone
- (206) 764-2163
Quick Facts
- NPI
- 1871177535
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile